News | September 21, 2022
Dolomite Bio launches an affordable microfluidic system for custom protocol development
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
Subscribe To Our Newsletter & Stay Updated
